查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1643503

心臟病學人工智慧的全球市場

Artificial Intelligence in Cardiology
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 172 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，心臟病學人工智慧全球市場預計將達到 43 億美元

2024 年全球心臟病學人工智慧市場規模估計為 13 億美元，預計到 2030 年將達到 43 億美元，2024-2030 年分析期內的複合年成長率為 22.7%。心臟病學 AI 硬體是該報告分析的細分市場之一，預計到分析期結束時複合年成長率為 22.3%，達到 17 億美元。預計分析期內心臟病學 AI 服務部門的複合年成長率為 19.9%。

美國市場規模估計為 3.289 億美元，中國市場預計複合年成長率為 21.6%

預計2024年美國心臟病學人工智慧市場規模將達3.289億美元。中國是世界第二大經濟體，預計到 2030 年市場規模將達到 6.541 億美元，2024-2030 年分析期間的複合年成長率為 21.6%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 20.7% 和 19.6%。在歐洲，預計德國的複合年成長率約為 15.7%。

全球心臟病學人工智慧市場—主要趨勢和促進因素摘要

人工智慧將如何改變心臟的診斷和治療？

人工智慧 (AI) 正在透過實現精準診斷、預測分析和個人化治療策略徹底改變心臟病學。心臟病學的傳統診斷方法通常依賴對影像、心電圖 (ECG) 和其他臨床資料的手動解釋，這既耗時又容易發生變化。人工智慧透過以驚人的速度和精度分析大型資料集，識別人類醫生可能忽視的模式和異常來解決這些挑戰。

例如，搭載人工智慧的影像診斷系統將提高冠狀動脈疾病、心律不整、心臟衰竭等疾病的診斷準確性。機器學習演算法處理超音波心動圖、 電腦斷層掃描和 MRI，以提供有關心臟功能和結構的詳細見解，從而實現更快、更準確的診斷。此外，人工智慧主導的心電圖分析系統可以即時檢測心律不整和其他電異常，確保及時干預，從而改善結果。

在治療計畫中，AI會分析患者的遺傳、病歷和生活方式等特定因素，以達到個人化治療。預測模型評估心血管事件的風險並指導醫生調整預防措施和治療計劃。這些進步凸顯了人工智慧在提高循環系統護理品質和效率方面的變革作用。

推動人工智慧在心臟病學領域應用的因素有哪些？

全球心血管疾病（CVD）負擔日益加重是循環系統領域採用人工智慧的關鍵促進因素。心血管疾病仍然是全球最大的死亡原因，需要創新的解決方案來加強預防、診斷和治療。人工智慧工具將使醫療保健專業人員能夠及早識別高風險患者並實施預防措施，從而降低這些疾病的盛行率和嚴重程度。

高品質臨床資料的日益普及是另一個重要因素。穿戴式裝置、遠端監控系統和電子健康記錄等資料收集技術的進步產生了大量心血管資料。人工智慧系統分析這些資料以發現可操作的見解，實現即時監控和決策。這種能力在偏遠和資源受限的環境中尤其有價值，因為這些地區無法獲得專門的心臟護理。

此外，遠端醫療平台和人工智慧的整合正在增強心臟病學服務的可及性。主導工具將透過分析患者資料並向醫生提供診斷建議來支援遠端諮詢。這種整合使得醫療保健更加便利和高效，特別是在醫療服務不足的地區。這些趨勢凸顯了人工智慧作為現代心臟病護理關鍵組成部分的日益依賴。

人工智慧能否改善患者治療效果並最佳化心血管照護？

人工智慧在改善患者治療效果和最佳化心血管護理方面發揮關鍵作用。透過實現更快、更準確的診斷，人工智慧可以降低併發症的風險並改善治療結果。預測分析工具可以識別心臟病和中風等疾病風險的患者，從而幫助醫療保健提供者實施預防措施以降低死亡率。

在外科手術和介入性心臟病學領域，人工智慧正在協助規劃和執行。人工智慧引導的機器人輔助系統將提高支架置入和瓣膜置換等手術的精確度，最大限度地降低風險並改善恢復結果。此外，人工智慧主導的臨床決策支援系統將協助醫生選擇最合適的治療方法，確保為個別患者提供最佳護理。

人工智慧在遠端患者監護中的作用也有助於改善治療效果。這款穿戴式裝置配備人工智慧演算法，可追蹤心率和血壓等生命徵象，以檢測病情惡化的早期預警訊號。這種即時監控使患者能夠有效地管理自己的病情，並允許醫生在必要時迅速介入。這些進步凸顯了人工智慧改變心血管照護和改善全球數百萬患者生活的潛力。

是什麼推動了心臟病學市場人工智慧的成長？

心臟病學市場人工智慧的成長由幾個關鍵因素推動，反映了其在解決心血管健康挑戰方面的變革潛力。心血管疾病的發生率不斷上升以及對先進診斷和治療解決方案的需求是主要的成長動力。人工智慧工具提高了循環系統工作流程的準確性和效率，以滿足日益成長的優質照護需求。

人工智慧演算法的技術進步，加上穿戴式裝置和遠端監控系統的廣泛使用，推動了該領域的持續創新。這些工具產生即時資料，由人工智慧系統進行分析，提供可操作的見解和個人化的護理建議。對人工智慧醫療設備的監管支援和對醫療技術的投資增加進一步推動了市場擴張。

消費者對便利、高效的醫療保健的期望也促進了人工智慧在心臟病學領域的應用。患者擴大尋求能夠主動進行健康管理的工具，而人工智慧解決方案則透過提供預測分析和遠端監控功能來滿足這一需求。這些因素加上正在進行的研究和開發，正在推動心臟病學人工智慧市場的快速成長，並使其成為未來心血管護理進步的關鍵。

部分

組件（硬體組件、服務組件、軟體組件）、醫療狀況（缺血性心臟疾病/CAD 醫療狀況、心律不整醫療狀況、心臟衰竭醫療狀況、其他醫療狀況）、應用程式（診斷應用程式、藥物研發應用程式、預測應用程式、其他應用程式）

受訪企業範例（共36家）

  • CardiAI, Inc.
  • Cleerly, Inc.
  • IDOVEN
  • Koninklijke Philips NV
  • RSIP Vision
  • Tempus AI, Inc.
  • UltraSight
  • Ultromics Limited
  • Vista.ai
  • Viz

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP29253

Global Artificial Intelligence in Cardiology Market to Reach US$4.3 Billion by 2030

The global market for Artificial Intelligence in Cardiology estimated at US$1.3 Billion in the year 2024, is expected to reach US$4.3 Billion by 2030, growing at a CAGR of 22.7% over the analysis period 2024-2030. Cardiology AI Hardware, one of the segments analyzed in the report, is expected to record a 22.3% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Cardiology AI Services segment is estimated at 19.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$328.9 Million While China is Forecast to Grow at 21.6% CAGR

The Artificial Intelligence in Cardiology market in the U.S. is estimated at US$328.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$654.1 Million by the year 2030 trailing a CAGR of 21.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 20.7% and 19.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 15.7% CAGR.

Global Artificial Intelligence in Cardiology Market - Key Trends & Drivers Summarized

How Is AI Transforming Cardiology Diagnostics and Treatment?

Artificial Intelligence (AI) is revolutionizing cardiology by enabling precise diagnostics, predictive analytics, and personalized treatment strategies. Traditional diagnostic methods in cardiology often rely on manual interpretation of imaging, electrocardiograms (ECGs), and other clinical data, which can be time-consuming and prone to variability. AI addresses these challenges by analyzing large datasets with unparalleled speed and accuracy, identifying patterns and abnormalities that might be overlooked by human practitioners.

For example, AI-powered imaging systems enhance the accuracy of diagnosing conditions such as coronary artery disease, arrhythmias, and heart failure. Machine learning algorithms process echocardiograms, CT scans, and MRIs to deliver detailed insights into cardiac function and structure, enabling earlier and more accurate diagnosis. Additionally, AI-driven ECG analysis systems detect arrhythmias and other electrical anomalies in real time, improving outcomes by ensuring timely intervention.

In treatment planning, AI is enabling personalized care by analyzing patient-specific factors such as genetics, medical history, and lifestyle. Predictive models assess the risk of cardiovascular events, guiding physicians in tailoring preventive measures and treatment plans. These advancements underscore AI’s transformative role in improving the quality and efficiency of cardiology care.

What Drives the Adoption of AI in Cardiology?

The rising global burden of cardiovascular diseases (CVDs) is a significant driver of AI adoption in cardiology. CVDs remain the leading cause of death worldwide, necessitating innovative solutions to enhance prevention, diagnosis, and treatment. AI-powered tools provide healthcare professionals with the ability to identify high-risk patients early and implement preventive measures, reducing the prevalence and severity of these conditions.

The increasing availability of high-quality clinical data is another critical factor. Advances in data collection technologies, such as wearable devices, remote monitoring systems, and electronic health records, generate vast amounts of cardiovascular data. AI systems analyze this data to uncover actionable insights, enabling real-time monitoring and decision-making. These capabilities are particularly valuable in remote and resource-constrained settings, where access to specialized cardiology care may be limited.

Moreover, the integration of AI with telemedicine platforms is enhancing access to cardiology services. AI-driven tools support remote consultations by analyzing patient data and providing physicians with diagnostic recommendations. This integration is improving care accessibility and efficiency, especially in underserved regions. These trends highlight the growing reliance on AI as a critical component of modern cardiology practice.

Can AI Improve Patient Outcomes and Optimize Cardiovascular Care?

AI is playing a pivotal role in improving patient outcomes and optimizing the delivery of cardiovascular care. By enabling earlier and more accurate diagnosis, AI reduces the risk of complications and enhances the effectiveness of treatments. Predictive analytics tools identify patients at risk of conditions such as heart attacks and strokes, allowing healthcare providers to implement preventive measures and reduce mortality rates.

In surgical and interventional cardiology, AI is assisting in planning and execution. Robotic-assisted systems guided by AI improve the precision of procedures such as stent placement and valve replacement, minimizing risks and improving recovery outcomes. Additionally, AI-driven clinical decision support systems aid physicians in selecting the most appropriate therapies, ensuring optimal care for individual patients.

AI’s role in remote patient monitoring is also contributing to better outcomes. Wearable devices equipped with AI algorithms track vital signs such as heart rate and blood pressure, detecting early warning signs of deterioration. This real-time monitoring empowers patients to manage their conditions effectively while enabling physicians to intervene promptly when necessary. These advancements underscore AI’s potential to transform cardiovascular care and improve the lives of millions of patients worldwide.

What’s Driving the Growth of the AI in Cardiology Market?

The growth in the Artificial Intelligence in Cardiology market is driven by several key factors, reflecting its transformative potential in addressing cardiovascular health challenges. The increasing prevalence of cardiovascular diseases and the associated demand for advanced diagnostic and therapeutic solutions are significant growth drivers. AI-powered tools enhance the accuracy and efficiency of cardiology workflows, meeting the growing need for high-quality care.

Technological advancements in AI algorithms, coupled with the proliferation of wearable devices and remote monitoring systems, are enabling continuous innovation in the field. These tools generate real-time data, which AI systems analyze to deliver actionable insights and personalized care recommendations. Regulatory support for AI-driven medical devices and growing investments in healthcare technology are further fueling market expansion.

Consumer expectations for accessible and efficient healthcare are also contributing to the adoption of AI in cardiology. Patients are increasingly seeking tools that enable proactive health management, and AI solutions address this demand by offering predictive analytics and remote monitoring capabilities. These factors, combined with ongoing research and development, are propelling the rapid growth of the AI in Cardiology market, positioning it as a cornerstone of future advancements in cardiovascular care.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence in Cardiology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Hardware Component, Services Component, Software Component); Medical Condition (Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition, Other Medical Conditions); Application (Diagnosis Application, Drug Discovery Application, Prediction Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 36 Featured) -

  • CardiAI, Inc.
  • Cleerly, Inc.
  • IDOVEN
  • Koninklijke Philips NV
  • RSIP Vision
  • Tempus AI, Inc.
  • UltraSight
  • Ultromics Limited
  • Vista.ai
  • Viz

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Artificial Intelligence in Cardiology - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • AI-Driven Cardiac Imaging Solutions Propel Growth in Early Diagnosis of Heart Conditions
    • Predictive Analytics in AI Strengthens Market for Risk Assessment in Cardiology
    • AI-Powered Wearable Devices Expand Opportunities in Remote Cardiac Monitoring
    • Advancements in AI-Enhanced ECG Analysis Drive Adoption in Diagnostic Centers
    • AI Algorithms for Detecting Heart Irregularities Strengthen Case for Faster Interventions
    • Integration of AI in Telecardiology Sets the Stage for Remote Healthcare Solutions
    • Demand for AI in Cardiac Rehabilitation Programs Spurs Adoption in Post-Care
    • AI Integration in Robotics for Cardiac Surgery Drives Demand in Minimally Invasive Techniques
    • Real-Time AI Insights for Blood Pressure Monitoring Propel Consumer Device Markets
    • AI in Remote Pacemaker Monitoring Highlights Consumer Health Potential
    • AI-Enhanced Cardiology Workflow Automation Drives Efficiency Across Hospitals
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence in Cardiology Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence in Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hardware Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Hardware Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Services Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Services Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Software Component by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Software Component by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Prediction Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Prediction Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Diagnosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Drug Discovery Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Drug Discovery Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Ischemic Heart Disease / CAD Medical Condition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Ischemic Heart Disease / CAD Medical Condition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiac Arrhythmias Medical Condition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Cardiac Arrhythmias Medical Condition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Heart Failure Medical Condition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Heart Failure Medical Condition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Other Medical Conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Other Medical Conditions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence in Cardiology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Component - Hardware Component, Services Component and Software Component - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Artificial Intelligence in Cardiology by Component - Percentage Breakdown of Value Sales for Hardware Component, Services Component and Software Component for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Application - Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Artificial Intelligence in Cardiology by Application - Percentage Breakdown of Value Sales for Prediction Application, Other Applications, Diagnosis Application and Drug Discovery Application for the Years 2025 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Cardiology by Medical Condition - Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Artificial Intelligence in Cardiology by Medical Condition - Percentage Breakdown of Value Sales for Ischemic Heart Disease / CAD Medical Condition, Cardiac Arrhythmias Medical Condition, Heart Failure Medical Condition and Other Medical Conditions for the Years 2025 & 2030

IV. COMPETITION